Moreover, ADPN inhibits hepatic fibrosis by downregulating HSC activation markers, including alpha-smooth muscle actin (α-SMA), transforming growth factor β1 (TGFβ-1), and pro-fibrotic genes [42]. Here, ADIPOQ is linked to Hepatic fibrosis.